Literature DB >> 26656194

ACR Appropriateness Criteria Review ACR Appropriateness Criteria® Occupational Lung Diseases.

Leon Bacchus1, Rakesh D Shah, Jonathan H Chung, Traves P Crabtree, Darel E Heitkamp, Mark D Iannettoni, Geoffrey B Johnson, Clinton Jokerst, Barbara L McComb, Anthony G Saleh, Robert M Steiner, Tan-Lucien H Mohammed, James G Ravenel.   

Abstract

Occupational lung disease is a category of disease entities characterized by a reaction of the lung parenchyma to inhaled aerosolized particles found in the environment. This document summarizes the imaging appropriateness data for silicosis, coal worker pneumoconiosis, and asbestosis. The main points of the document are that computed tomography is more sensitive than radiography, computed tomography without contrast generally suffices for evaluation, and fluorodeoxyglucose-positron emission tomography may have utility in patients with mesothelioma. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review includes an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26656194     DOI: 10.1097/RTI.0000000000000194

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  1 in total

1.  Temporal Patterns of Exposure to Asbestos and Risk of Asbestosis: An Analysis of a Cohort of Asbestos Textile Workers.

Authors:  Andrea Farioli; Francesco S Violante; Carlo La Vecchia; Eva Negri; Claudio Pelucchi; Giovanna Spatari; Paolo Boffetta; Enrico Pira
Journal:  J Occup Environ Med       Date:  2018-06       Impact factor: 2.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.